MEI Pharma Inc reports results for the quarter ended in September - Earnings Summary

Lite Strategy

14/11/2022 21:26

* MEI Pharma Inc  MEIP.OQ  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 14 cents per share.
    * Revenue fell 34.8% to $8.73 million from a year ago;
analysts
expected $5.90 million. 
    * MEI Pharma Inc's reported EPS for the quarter was a loss
of 12
cents​.
    * The mean earnings estimate of analysts had risen by
about 37.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * MEI Pharma Inc shares had fallen by 12.6% this quarter and
lost 87.3% so far this year.
    * The company reported a quarterly loss of $16.62 million.
    * Wall Street's median 12-month price target for MEI Pharma
Inc is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 09:25 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.14          -0.12          Beat
 Jun. 30 2022      -0.19          -0.12          Beat
 Mar. 31 2022      -0.18          -0.07          Beat
 Dec. 31 2021      -0.20          -0.05          Beat